"Clinically predictive preclinical efficacy testing services at your disposal"


Jussi Halleen - CEO, Pharmatest Services

Pharmatest Services Ltd attends EORTC-NCI-AACR Meeting in Munich

Pharmatest Services Ltd attends the EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics that will be held in Munich, Germany on November 29 – December 2, 2016. Pharmatest presents two scientific poster presentations in the conference.

Pharmatest Services Ltd (Pharmatest) is a contract research organization that offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. The EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics is organized by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI), and the American Association for Cancer Research (AACR).

This year Pharmatest attends the EORTC-NCI-AACR conference with the following two scientific poster presentations:

- Poster P126 on Tuesday, November 29: Presence of immune infiltrates in early phases of prostate cancer: Establishment of a preclinical efficacy model to promote immunotherapy development

- Poster P065 on Wednesday, November 30: Differential drug sensitivity score (DSS) for indolent and aggressive prostate cancer cell lines (in collaboration with FIMM)

Pharmatest welcomes everyone to visit our posters. If you would like to schedule a meeting with our representatives during the ASBMR meeting, click here.